Contemporary Mohs surgery applications

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 4, 2008, Pages 376-380

  Minton, Timothy J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Basal cell carcinoma; Cutaneous malignancy; Melanoma; Mohs micrographic surgery; Skin cancer; Squamous cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

CANCER SURGERY; CHEMOSURGERY; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TREATMENT INDICATION; BASAL CELL CARCINOMA; HEAD AND NECK TUMOR; METHODOLOGY; PATHOLOGY; PROGNOSIS; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; MELANOMA; MOHS SURGERY; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; SKIN; SKIN NEOPLASMS;

EID: 52449101969     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283079cac     Document Type: Review

References (25)

1. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol 1995; 13:617-620.
2. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15:424-431.
3. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15:315-328.
4. Snow SN, Madjar DD Jr. Mohs surgery in the management of cutaneous malignancies. Clin Dermatol 2001; 19:339-347.
5. Kaplan AL, Weitzul SB, Taylor RS. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery. Dermatol Surg 2008; 34:15-19.
6. Mohs F. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 1941; 42:279-295.
7. Tromovitch TA, Stegeman SJ. Microscopically controlled excision of skin tumors. Arch Dermatol 1974; 110:231-232.
8. Huang CC, Boyce S, Northington M, et al. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micro-graphic surgery. J Am Acad Dermatol 2004; 51:585-591.
9. Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg 2005; 62:518-526.
10. Davidson TM, Haghighi P, AstaritaR, et al. MOHS for head and neck mucosal cancer: report on 111 patients. Laryngoscope 1988; 98:1078-1083.
11. GauthierP, NgoH, AzarK, et al. Mohs surgery - a new approach with a mould and glass discs: review of the literature and comparative study. J Otolaryngol 2006; 35:292-304.
12. Smeets NW, Kuijpers DI, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face: results of a retrospective study and review of the literature. Br J Dermatol 2004; 151:141 -147.
13. Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364:1766-1772.
14. Carucci JA. Mohs' micrographic surgery for the treatment of melanoma. Dermatol Clin 2002; 20:701 -708.
15. Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg 2007; 33:395-402.
16. Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg 2008; 34:1 -5.
17. Bricca GM, Brodland DG, Ren D, et al. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52:92-100.
18. Walling HW, Scupham RK, Bean AK, et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 2007; 57:659-664.
19. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37:236-245.
20. Manstein ME, Manstein CH, Smith R. How accurate is frozen section for skin cancers? Ann Plast Surg 2003; 50:607-609.
21. Brandt MG, Moore CG. Randomized control trial of flourescence-guided surgical excision of nonmelanotic malignancies. J Otolaryngol 2007; 36: 148-155.
22. Redondo P, Marquina M, Pretel M, et al. Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. Arch Dermatol 2008; 144:115-117.
23. Stenquist B, Ericson MB, Strandeberg C, et al. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery. Br J Dermatol 2006; 154:305-309.
24. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998; 39:698-703.
25. Essers BA, Dirksen CD, Nieman FH, et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006; 142:187-194.